CLINICAL_TRIALS
trial_result
· 2025-12-08
Clinical Trial Update: A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus [Phase 2]
Summary
A Phase 2 study evaluating Nipocalimab in adults with active systemic lupus erythematosus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED